{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:14:48Z","timestamp":1761556488152,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.sapharm.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T23:40:47Z","timestamp":1428277247000},"page":"29-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["An evaluation of three statistical estimation methods for assessing health policy effects on prescription drug claims"],"prefix":"10.1016","volume":"12","author":[{"given":"Manish","family":"Mittal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald L.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tze","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2015.03.004_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/CIRCULATIONAHA.107.714618","article-title":"A primer in longitudinal data analysis","volume":"118","author":"Fitzmaurice","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2015.03.004_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/heapol\/czr004","article-title":"How to do (or not to do) \u2026 Assessing the impact of a policy change with routine longitudinal data","volume":"27","author":"Lagarde","year":"2012","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.sapharm.2015.03.004_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MLR.0b013e318245a160","article-title":"Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review","volume":"50","author":"Dusetzina","year":"2012","journal-title":"Med Care"},{"volume":"2012","year":"2012","author":"Briesacher","key":"10.1016\/j.sapharm.2015.03.004_bib4"},{"key":"10.1016\/j.sapharm.2015.03.004_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ps.2010.61.1.11","article-title":"Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?","volume":"61","author":"Busch","year":"2010","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.sapharm.2015.03.004_bib6","first-page":"17","article-title":"Changes in antidepressant medications prescribing trends in children and adolescents in Hawai'i following the FDA black box warning","volume":"69","author":"Hassanin","year":"2010","journal-title":"Hawaii Med J"},{"key":"10.1016\/j.sapharm.2015.03.004_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1067\/mcp.2002.129503","article-title":"The impact of wording in \u201cDear doctor\u201d letters and in black box labels","volume":"72","author":"Weatherby","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.sapharm.2015.03.004_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pds.592","article-title":"Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of \u2018Dear Doctor\u2019 letters","volume":"10","author":"Weatherby","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2015.03.004_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0009-9236(97)90185-5","article-title":"Temporal decline in filling prescriptions for terfenadine closely in time with those for either ketoconazole or erythromycin","volume":"61","author":"Burkhart","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.sapharm.2015.03.004_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/pds.961","article-title":"Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants","volume":"14","author":"Shatin","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2015.03.004_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00004583-200207000-00009","article-title":"A study of compliance with FDA recommendations for pemoline (Cylert)","volume":"41","author":"Willy","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"year":"2007","series-title":"An Introduction to Categorical Data Analysis","author":"Agresti","key":"10.1016\/j.sapharm.2015.03.004_bib12"},{"key":"10.1016\/j.sapharm.2015.03.004_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/0013164404272502","article-title":"A comparison of missing-data procedures for arima time-series analysis","volume":"65","author":"Velicer","year":"2005","journal-title":"Educ Psychol Meas"},{"key":"10.1016\/j.sapharm.2015.03.004_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach","volume":"44","author":"Zeger","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.sapharm.2015.03.004_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yebeh.2014.03.017","article-title":"Have antiepileptic drug prescription claims changed following the FDA suicidality warning? An evaluation in a state Medicaid program","volume":"34","author":"Mittal","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"12","key":"10.1016\/j.sapharm.2015.03.004_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/pds.3272","article-title":"Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory","volume":"21","author":"Dusetzina","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2015.03.004_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/MLR.0b013e3181ef9d2b","article-title":"Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression","volume":"48","author":"Valluri","year":"2010","journal-title":"Med Care"},{"year":"2013","series-title":"The GLIMMIX Procedure: PROC GLIMMIX Contrasted with Other SAS Procedures","key":"10.1016\/j.sapharm.2015.03.004_bib18"},{"key":"10.1016\/j.sapharm.2015.03.004_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archgenpsychiatry.2009.179","article-title":"Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA\/APA recommendations for second-generation antipsychotic drugs","volume":"67","author":"Morrato","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.sapharm.2015.03.004_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2307\/1403572","article-title":"A comparison of cluster-specific and population-averaged approaches for analyzing correlated binary data","volume":"59","author":"Neuhaus","year":"1991","journal-title":"Int Stat Rev"},{"key":"10.1016\/j.sapharm.2015.03.004_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrrheum.2013.93","article-title":"Spondyloarthritis: Is it time to replace BASDAI with ASDAS?","volume":"9","author":"Machado","year":"2013","journal-title":"Nat Rev Rheumatol"},{"year":"2007","series-title":"Using Arrays to Calculate Medication Utilization","author":"Leslie","key":"10.1016\/j.sapharm.2015.03.004_bib22"},{"key":"10.1016\/j.sapharm.2015.03.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2137284","article-title":"Revisiting the behavioral model and access to medical care: does it matter?","volume":"36","author":"Andersen","year":"1995","journal-title":"J Health Soc Behav"},{"issue":"suppl 1","key":"10.1016\/j.sapharm.2015.03.004_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pds.2329","article-title":"A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data","volume":"21","author":"Kee","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"volume":"2013","year":"2008","author":"Mentari","key":"10.1016\/j.sapharm.2015.03.004_bib25"},{"key":"10.1016\/j.sapharm.2015.03.004_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nurt.2006.10.003","article-title":"Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain","volume":"4","author":"Ettinger","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.sapharm.2015.03.004_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200822010-00003","article-title":"Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy","volume":"22","author":"Johannessen Landmark","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sapharm.2015.03.004_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.sapharm.2015.03.004_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.sapharm.2015.03.004_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2015.03.004_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"article-title":"Time series analysis","year":"1990","series-title":"Sage University Papers Series on Quantitative Applications in the Social Sciences","key":"10.1016\/j.sapharm.2015.03.004_bib32"},{"key":"10.1016\/j.sapharm.2015.03.004_bib33","first-page":"409","article-title":"Testing for serial correlation in least square regression","volume":"37","author":"Watson","year":"1951","journal-title":"Biometrika"},{"year":"1983","series-title":"Generalized Linear Models","author":"McCullagh","key":"10.1016\/j.sapharm.2015.03.004_bib34"},{"key":"10.1016\/j.sapharm.2015.03.004_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/EDE.0b013e3181caeb90","article-title":"To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health","volume":"21","author":"Hubbard","year":"2010","journal-title":"Epidemiology"},{"year":"2004","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","key":"10.1016\/j.sapharm.2015.03.004_bib36"},{"key":"10.1016\/j.sapharm.2015.03.004_bib37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/aje\/kwf215","article-title":"Statistical analysis of correlated data using generalized estimating equations: an orientation","volume":"157","author":"Hanley","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sapharm.2015.03.004_bib38","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1002\/sim.3340","article-title":"Analysis of longitudinal data to evaluate a policy change","volume":"27","author":"French","year":"2008","journal-title":"Stat Med"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741115000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741115000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:11:09Z","timestamp":1761556269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741115000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1551741115000704"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2015.03.004","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An evaluation of three statistical estimation methods for assessing health policy effects on prescription drug claims","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}